Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to look at how fast commercially available supplements containing carbohydrate can get into the bloodstream. If carbohydrate, in the form of glucose, gets into the blood faster, this can provide an instant energy source and help fuel the body during exercise. We will be testing three supplements, namely Voom Pocket Rocket, SIS Go Isotonic Energy Gel, and Maurten Gel 160. Each participant will complete all three conditions, consuming one of each supplement at random per condition. The study requires participation from male runners, cyclists and triathletes who are aged between 18-35. Each visit will take approximately 1 hour and 30 minutes, and three experimental visits per participant. The study will involve frequent blood sampling and the continuous monitoring of gas exchange (oxygen/carbon dioxide). Blood sampling via cannulation will be used to analyse the lactate, glucose, and insulin content of the blood. Gas exchange will measure the oxygen breathed in and carbon dioxide breathed out throughout the study. The investigators plan to carry out the study on 16 participants who will be a mix of male runners, cyclists and triathletes.


Clinical Trial Description

The aim of this study is to investigate and compare the speed of delivery of three commercially available carbohydrate supplements during a 1 hour modified glucose tolerance test. This study will be a randomised double-blind crossover in design. Participants will be required to attend the Human Performance Laboratory at Lancaster University on three separate visits. During each visit, participants will be required to consume one of three commercially available carbohydrate supplements, namely Maurten Gel 160 (MAU), Voom Pocket Rocket Electro Energy Bar (PR), and SIS Go Isotonic Energy Gel (SIS). Each consumable will be blinded to both the researchers and participants, flavoured the same (lemon and lime) and placed into identical packaging with anonymised labelling to minimise the risk of bias. The supplements will be matched for carbohydrate content (45 grams). Blinding of supplements will be completed offsite by people not in the research team and followed strict food and hygiene protocols. Each participant will complete all three conditions, consuming one of each supplement at random per condition. Each visit will involve frequent blood sampling for glucose, lactate and insulin, via a retrograde venous cannula will inserted into the dorsal surface of their non-dominant arm by a qualified member of the research team. It is fitted in the opposite direction to an anterograde cannula which allows for the collection of distal blood samples where arterial venous shunting is likely to occur. The participants hand and lower forearm will be then placed into a heated box to allow for the arterialisation of the blood. This is a less invasive alternative to arterial cannulisation whilst still allowing for accurate metabolic measures to be taken. Once the retrograde venous cannula is inserted and secured in place, a resting measurement of blood will be taken (1ml of blood taken to measure glucose and lactate, and 3ml for insulin). Participants will then be required to consume one of the three carbohydrate energy supplements. Once the supplement had been consumed, continuous gas analysis will begin to analyse gas exchange to non-invasively measure substrate utilisation. This signals the start of the test, and a timer will be set for 1 hour. Throughout the test, blood sampling will be taken in frequent intervals. 1ml of blood sampled every 5 minutes to check for glucose and lactate, and 3ml of blood sampled every 10 minutes for insulin. Gas exchange will be continuously measured to non-invasively measure substrate utilization in the muscle via indirect calorimetry which determines energy expenditure by measuring the body's oxygen consumption and carbon dioxide production. The measurement is based on the assumption that the volume of oxygen (VO2) consumed is used to oxidise fuels, and the volume of carbon dioxide (VCO2) produced is a by-product of substrate utilisation. After the study visit, analysis will be conducted assessing how each of the three supplements effect blood glucose, blood lactate, insulin, and gas exchange. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06375577
Study type Interventional
Source Lancaster University
Contact Ewan T Dean
Phone +44 07807816414
Email e.dean1@lancaster.ac.uk
Status Recruiting
Phase N/A
Start date June 2024
Completion date April 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1